Cognitive deficits in recent-onset and chronic schizophrenia

https://doi.org/10.1016/j.jpsychires.2009.09.010Get rights and content

Abstract

Although cognitive dysfunction is a primary characteristic of schizophrenia, only recently have investigations begun to pinpoint when the dysfunction develops in the individual afflicted by the disorder. Research to date provides evidence for significant cognitive impairments prior to disorder onset. Less is known about the course of cognitive dysfunction from onset to the chronic phase of schizophrenia. Although longitudinal studies are optimal for assessing stability of cognitive deficits, practice effects often confound assessments, and large and representative subject samples have not been followed over long periods of time. We report results of a cross-sectional study of cognitive deficits early and late in the course of schizophrenia carried out at four different geographic locations to increase sample size and generalizability of findings. We examined a broad set of cognitive functions in 41 recent-onset schizophrenia patients and 106 chronic schizophrenia patients. The study included separate groups of 43 matched controls for the recent-onset sample and 105 matched controls for the chronic schizophrenia sample in order to evaluate the effects of cohort (i.e., age) and diagnosis (i.e., schizophrenia) on cognitive functions. All measures of cognitive function showed effects of diagnosis; however, select time-based measures of problem solving and fine motor dexterity exhibited interactions of diagnosis and cohort indicating that these deficits may progress beyond what is expected with normal aging. Also, worse recall of material in episodic memory was associated with greater length of illness. Nevertheless, findings indicate that nearly all cognitive deficits are comparably impaired across recent-onset and chronic schizophrenia.

Introduction

Cognitive dysfunction is increasingly considered a primary characteristic of schizophrenia. Researchers have begun to detail when the dysfunction develops in the individual afflicted by the disorder. A preponderance of evidence indicates that cognitive deficits are apparent in the adolescent with schizophrenia and at the first-episode of the disorder (Addington et al., 2005, Bilder et al., 2000, Cervellione et al., 2007, Hawkins et al., 2008, Kenny et al., 1997, Mesholam-Gately et al., 2009), as well as being relatively consistent in severity over a chronic course of the disorder (Albus et al., 2006, Hoff et al., 1999, Hoff et al., 2005, Rund et al., 2007, Stirling et al., 2003). Impaired cognitive function is also clearly present prior to disorder onset during the premorbid period (Woodberry et al., 2008). Recent work on the period prior to frank psychosis has nonetheless provided evidence for cognitive declines prior to disorder onset (Fuller et al., 2002) from premorbid impairment to greater postmorbid impairment (Caspi et al., 2003, Seidman et al., 2006). Some studies also indicate an additional period of accelerated cognitive decline late in life in some subgroups of institutionalized schizophrenia patients (Friedman et al., 2001, Harvey et al., 1999). Thus, the first period of cognitive impairment may be a manifestation of neurodevelopmental processes that become fully expressed in late adolescence, and the latter may reflect vulnerability of the schizophrenic brain to aging and dementia late in life (Kurtz et al., 2005). Although there is a substantial evidence for largely comparable cognitive impairment during first-episode and chronic schizophrenia, (Heinrichs and Zakzanis, 1998), very few studies have used the same measures to directly compare two independent samples of subjects at these substantially different phases of the illness.

Although individuals with schizophrenia generally manifest stable and impaired cognitive function that is possibly bracketed by cognitive declines prior to disorder onset and preceding death in old age, the possibility that select cognitive deficits may be increasingly impaired over time has not been ruled out. For example, there is some evidence for an age-associated cognitive decline in complex information processing and executive functions in schizophrenia (Bowie et al., 2008, Fucetola et al., 2000, Granholm et al., 2000, Mesholam-Gately et al., 2009). Also, motor functions have been identified as a primary dimension of cognition in schizophrenia (Jaeger et al., 2003) and shown to be increasingly impaired over extended follow-up periods. Kurtz et al. (2005) provided evidence of slowing in speeded motor sequencing in chronic schizophrenia over a 10-year period while all other cognitive domains assessed remained the same. Gold et al. (1999) also found in the context of relatively stable or improved cognitive function over 5 years, schizophrenia patients’ performance declined on a test of simple finger tapping. Decline in motor function also appears to be associated with the onset of psychosis (Hawkins et al., 2008). Yet, other studies have demonstrated preserved simple motor functions over 1–2 years (Addington et al., 2005) and over a 10-year longitudinal period (Hoff et al., 2005). Although longitudinal studies provide a direct test for change in cognitive functions, variability in the findings from these studies may stem from reliance on small control samples, patients being lost to follow-up, short longitudinal periods of only 1–2 years, changes in motor function due to antipsychotic exposure, and variation in use of first and second generation antipsychotic medication (Weickert and Goldberg, 2005).

In order to characterize several domains of cognitive function in early and chronic phases of the disorder, and to test for evidence of progression in executive and motor dysfunction, the present study examined a broad set of cognitive and motor functions in recent-onset and chronic schizophrenia patients. Subjects were studied in four different geographic regions in the United States of America to increase generalizability of findings. The study also included separate control groups for recent-onset and chronic schizophrenia samples drawn from the four sites so effects of age (i.e., cohort) and schizophrenia (i.e., diagnosis) could be separated in analyses. We hypothesized that cognitive impairments would be comparable across the two samples, with the possible exception of impairments of motor and executive functions being larger in the chronic patients.

Section snippets

Study participants

Subjects were recruited through the University of New Mexico in Albuquerque, University of Iowa in Iowa City, Massachusetts General Hospital and the Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center of the Beth Israel Deaconess Medical Center, Boston, and the University of Minnesota in Minneapolis as part of the Mental Illness and Neuroscience Discovery (MIND) Clinical Imaging Consortium (MCIC). All subjects were required to be at least

Results

On matching variables, all groups had similar parental socio-economic status, and the recent-onset and chronic schizophrenia samples were of similar age to their respective control groups (see Table 1). The controls for chronic schizophrenia patients had a higher percentage of females, thus gender was specified as a factor in subsequent analyses. Both schizophrenia groups had significantly lower reading achievement (regarded as an estimate of premorbid intelligence), suggesting that

Discussion

Contrasts of cognitive functions in recent-onset and chronic schizophrenia patients from four geographic regions with separate matched control samples yielded evidence for similar cognitive deficits from shortly after onset to chronic phases of the disorder. Two measures for the amount of time taken to plan and problem solve showed diagnosis and cohort interactions suggesting progressive impairment from recent-onset to chronic schizophrenia, but these effects failed to survive correction for

Role of funding source

Funding for this study was provided by Department of Energy (DE-FG03-99ER62764) and the work was carried out as part of the MIND Research Network. Commonwealth Research Center, Massachusetts Department of Mental Health (L.J.S., R.M.G.) provided support at one of the sites. The Department of Energy had no further role in the study design, in the collection of data, in the writing of the report, and in the decision to submit the paper for publication.

Contributors

Dr. Sponheim assisted in design of the cognitive assessment battery, reviewed data, conducted data analyses, and wrote the manuscript for publication. Dr. Jung oversaw and designed the administration of the cognitive test battery across sites and directed the collection of cognitive data. Drs. Seidman, Mesholam-Gately, Manoach, and O’Leary designed the cognitive assessment battery and assisted in site-specific data collection and preparation of the manuscript. Drs. Ho, Andreasen, and Lauriello

Conflict of interest

Because the study was only funded through the Department of Energy and the report is focused on cognitive indices all authors declare that they have no conflicts of interest.

Acknowledgements

We thank the psychometrists and clinical raters of the MCIC sites (Albuquerque, Iowa City, Boston, and Minneapolis) within the MIND research network.

References (50)

  • M.M. Kurtz

    Neurocognitive impairment across the lifespan in schizophrenia: an update

    Schizophrenia Research

    (2005)
  • P. Premkumar et al.

    Neuropsychological function-brain structure relationships and stage of illness: an investigation into chronic and first-episode schizophrenia

    Psychiatry Research

    (2008)
  • B.R. Rund et al.

    The course of neurocognitive functioning in first-episode psychosis and its relation to premorbid adjustment, duration of untreated psychosis, and relapse

    Schizophrenia Research

    (2007)
  • J. Stirling et al.

    Neurocognitive function and outcome in first-episode schizophrenia: a 10-year follow-up of an epidemiological cohort

    Schizophrenia Research

    (2003)
  • N.E. van Haren et al.

    Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood

    Biological Psychiatry

    (2008)
  • L. Zipparo et al.

    Investigating the neuropsychological and neuroanatomical changes that occur over the first 2–3 years of illness in patients with first-episode schizophrenia

    Progress in Neuro-Psychopharmacology and Biological Psychiatry

    (2008)
  • M. Albus et al.

    Neurocognitive functioning in patients with first-episode schizophrenia: results of a prospective 5-year follow-up study

    European Archives of Psychiatry and Clinical Neuroscience

    (2006)
  • M. Annett

    A classification of hand preference by association analysis

    British Journal of Psychology

    (1970)
  • A.L. Benton

    The visual retention test as a constructional praxis task

    Confina Neurologica

    (1962)
  • R.M. Bilder et al.

    Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates

    American Journal of Psychiatry

    (2000)
  • J. Brandt

    The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms

    The Clinical Neuropsychologist

    (1991)
  • M.A. Cirillo et al.

    Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms

    Neuropsychology Review

    (2003)
  • D.C. Delis et al.

    Delis–Kaplan Executive Function System

    (2001)
  • J.I. Friedman et al.

    Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer’s disease and normal aging

    American Journal of Psychiatry

    (2001)
  • R. Fuller et al.

    Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance

    American Journal of Psychiatry

    (2002)
  • Cited by (96)

    View all citing articles on Scopus

    Presented in part at the 14th biennial Winter Workshop on Schizophrenia and Bipolar Disorders, Montreux, Switzerland.

    View full text